{"id":104378,"name":"KEMPHARM, INC.","slug":"kempharm-inc","state":"IA","country":"United States of America","description":"Pharmaceutical company engaged in the discovery and development of proprietary prodrugs","totalSpending":70000,"filings":3,"yearlySpending":[{"year":2018,"income":70000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"PHA","display":"Pharmacy"}],"firms":["ARENTFOX SCHIFF LLP"],"lobbyists":["PHILIP ENGLISH","NORMAN LENT","SONJA NESBIT"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","White House Office"],"sampleDescriptions":["Prodrug therapies and improving abuse deterrence and consumer safety\nAnti-opioid abuse deterrent legislation","FDA regulation of opioid abuse deterrent formulations","FDA regulation of opioid abuse deterrent formulations","Prodrug therapies and improving abuse deterrence and consumer safety\nAnti-opioid abuse deterrent legislation \nH.R. 6 (SUPPORT for Patients and Communities Act), provisions relating to HHS study on abu","FDA regulation of opioid abuse deterrent formulations"]}